Department of Endocrinology, General Hospital of Ningxia Medical University, Yinchuan, China.
Neuroscience Center, General Hospital of Ningxia Medical University, Yinchuan, China.
Front Endocrinol (Lausanne). 2022 Aug 5;13:928591. doi: 10.3389/fendo.2022.928591. eCollection 2022.
Hyperglycemia is one of the major risk factors for stroke and stroke recurrence, leading to aggravated neuronal damage after cerebral ischemia/reperfusion (I/R). ERK1/2 signaling pathway plays a vital role in cerebral ischemic injury. However, the role of the ERK1/2 pathway in hyperglycemia-aggravated ischemic brain damage is not clear.
Streptozotocin (STZ; 50 mg/kg)-induced diabetes (blood glucose ≥12 mmol/L) or control groups in adult Sprague-Dawley rats were further subdivided into I/R (carotid artery/vein clamping), I/R + PD98059 (I/R plus ERK1/2 inhibitor), and Sham-operated groups (n = 10 each). Neurobehavioral status (Neurological behavior scores) and the volume of the cerebral infarction (TTC staining); brain mitochondrial potential (JCI ratio test) and cell apoptosis (TUNEL assay); RAS protein expression, phosphorylated/total ERK1/2 and Drp-1 (Dynamic-related protein 1) protein levels (Western blotting); mitochondrial fusion-related proteins mitofusin-1/2 (Mfn1/2), optic atrophy (OPA-1) and mitochondrial fission 1 (Fis1), and autophagy-associated proteins Beclin-1, LC3-I/II and P62 (Western blotting and immunohistochemistry) were analyzed.
The I/R + PD98059 group demonstrated better neurobehavior on the 1 (p < 0.05) and the 3 day (p < 0.01) than the I/R group. Compared to the Sham group, cerebral ischemia/reperfusion brought about neuronal damage in the I/R group (p <0.01). However, treatment with PD98059 showed an improved situation with faster recovery of mitochondrial potential and less apoptosis of neuronal cells in the I/R + PD98059 group (p < 0.01). The I/R group had a higher-level expression of RAS and phosphorylated ERK1/2 and Drp-1 than the diabetes mellitus (DM) group (p < 0.01). The PD98059 treated group showed decreased expression of p-ERK1/2, p-Drp-1, Fis1, and Beclin-1, LC3-I/II and P62, but increased Mfn1/2 and OPA-1 than the I/R group (p < 0.01).
Hyperglycemia worsens cerebral ischemia/reperfusion-induced neuronal damage ERK1/2 activated cell autophagy and mitochondrial fission.
高血糖是中风和中风复发的主要危险因素之一,导致脑缺血/再灌注(I/R)后神经元损伤加重。ERK1/2 信号通路在脑缺血损伤中起着至关重要的作用。然而,ERK1/2 通路在高血糖加重缺血性脑损伤中的作用尚不清楚。
链脲佐菌素(STZ;50mg/kg)诱导的糖尿病(血糖≥12mmol/L)或对照组成年 Sprague-Dawley 大鼠进一步分为 I/R(颈总动脉/颈静脉夹闭)、I/R+PD98059(I/R 加 ERK1/2 抑制剂)和假手术组(每组 10 只)。神经行为状态(神经行为评分)和脑梗死体积(TTC 染色);脑线粒体电位(JCI 比值试验)和细胞凋亡(TUNEL 检测);RAS 蛋白表达、磷酸化/总 ERK1/2 和 Drp-1(动态相关蛋白 1)蛋白水平(Western 印迹);线粒体融合相关蛋白线粒体融合蛋白 1/2(Mfn1/2)、视神经萎缩(OPA-1)和线粒体分裂 1(Fis1)和自噬相关蛋白 Beclin-1、LC3-I/II 和 P62(Western 印迹和免疫组化)进行分析。
与 I/R 组相比,I/R+PD98059 组在第 1 天(p<0.05)和第 3 天(p<0.01)的神经行为更好。与假手术组相比,脑缺血再灌注导致 I/R 组神经元损伤(p<0.01)。然而,PD98059 治疗组显示出更好的情况,即 I/R+PD98059 组的线粒体电位恢复更快,神经元细胞凋亡减少(p<0.01)。与糖尿病组相比,I/R 组 RAS 和磷酸化 ERK1/2、Drp-1 的表达水平更高(p<0.01)。PD98059 处理组的 p-ERK1/2、p-Drp-1、Fis1、Beclin-1、LC3-I/II 和 P62 的表达水平降低,但 Mfn1/2 和 OPA-1 的表达水平升高(p<0.01)。
高血糖加重脑缺血/再灌注诱导的神经元损伤,激活 ERK1/2 细胞自噬和线粒体分裂。